All terms in EFO
| Label | Id | Description |
|---|---|---|
| cortical thickness change measurement | EFO_0021501 | [Quantification of the change in cortical thickness over time.] |
| amphiprotic solvent role | CHEBI_4836 | [An oxazinooxazine that has formula C12H23NO2., A docosenoic acid that has formula C22H42O2.] |
| cortex volume change measurement | EFO_0021500 | [Quantification of the change in cortex volume over time.] |
| obsolete_partial trisomy of the long arm of chromosome 20 | Orphanet_262995 | |
| Large for gestational age | HP_0001520 | [The term large for gestational age applies to babies whose birth weight lies above the 90th percentile for that gestational age.] |
| Increased body weight | HP_0004324 | [Abnormally increased body weight.] |
| Populus balsamifera | NCBITaxon_73824 | |
| Mytilus trossulus | NCBITaxon_6551 | |
| obsolete_Generalized pustular psoriasis | Orphanet_247353 | [Generalized pustular psoriasis (GPP) is a severe inflammatory skin disease that can be life-threatening and that is characterized by recurrent episodes of high fever, fatigue, episodic erythematous cutaneous eruptions with sterile cutaneous pustules formation on various parts of the body, and neutrophil leukocytosis.] |
| clinically amyopathic dermatomyositis | EFO_0008532 | [Subset of dermatomyositis that lacks distinct muscle features and often manifests rapidly progressive interstitial pneumonia (RPIP).] |
| dyspepsia | EFO_0008533 | [An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease. [ NCIt:C26756 ], An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.] |
| tryptophan measurement | EFO_0008534 | [Quantification of the levels of tryptophan in a sample, typically cerebrospinal fluid or blood] |
| Mytilus californianus | NCBITaxon_6549 | |
| Streptococcus dysgalactiae subsp. equisimilis | NCBITaxon_119602 | |
| post-traumatic stress disorder symptom measurement | EFO_0008535 | [Quantification of the severity of post-traumatic stress disorder symptoms, typically quantified as the sum score of items of a diagnostic instrument such as the Semi-Structured Assessment for the Genetics of Alcoholism] |
| post-traumatic stress disorder | EFO_0001358 | [An anxiety disease which results from a traumatic experience that results in psychological trauma., An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by intrusive recurring thoughts or images of the traumatic event; avoidance of anything associated with the event; a state of hyperarousal and diminished emotional responsiveness. These symptoms are present for at least one month and the disorder is usually long-term., A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event., A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event (MeSH).] |
| kynurenine:tryptophan ratio | EFO_0008530 | [Quantification of the ration of kynurenine to tryptophan in plasma.] |
| kynurenine measurement | EFO_0008529 | [Quatification of plasma levels of kynurenine, a ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.] |
| GLP-1-stimulated insulin response | EFO_0008531 | [Quantification of insulin release in response to stimulation with GLP-1, typically measured under hyperglycemic clamp.] |
| glucose homeostasis | GO_0042593 | [Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.] |